Holding(s) in Company

Allergy Therapeutics PLC
06 December 2005


Allergy Therapeutics plc ("the Company")


The Company received notification on 5 December 2005 that Fidelity International
Limited ("FIL") and its direct and indirect subsidiaries, including Fidelity
Investment Services Ltd ("FISL"), Fidelity Gestion (FIGEST), Fidelity
Investments Advisory (Korea) Limited (FIA(K)L), Fidelity Investments Management
(Hong Kong) Limited (FIMHK), Fidelity Pension Management ("FPM") and Fidelity
Investments International (FII), investment managers for various non-US
investment companies and institutional clients, are together interested in a
total of 5,810,344 ordinary shares in the Company, representing approximately
9.23 per cent. of the Company's issued share capital.

This shareholding is registered as follows:

     Shares held        Management            Nominee/Registered Name
                        Company

     8,400              N/A                   N/A
     739,500            FPM                   Northern Trust London
     530,600            FPM                   Mellon Bank
     485,262            FPM                   Bank of New York Brussels
     428,500            FPM                   JP Morgan
     348,584            FPM                   State Str Bk and TR Co LDDN
     206,600            FPM                   Bankers Trust
     104,600            FPM                   Midland Securities Services
     75,000             FPM                   Clydesdale Bank plc
     1,984,798          FISL                  JP Morgan
     793,100            FIL                   Brown Bros Harrimn Ltd Lux
     105,400            FIL                   Bank of New York Brussels

     5,810,344                                Total holding


This notifiable interest also comprises the notifiable interest of Mr Edward C.
Johnson III, a principal shareholder of Fidelity International Limited, and
interests held on behalf of authorised unit trust schemes in the United Kingdom.




                      This information is provided by RNS
            The company news service from the London Stock Exchange